A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
Clinical trial NCT02450331 · TERMINATED
Trial details
- NCT number
- NCT02450331
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-05
- Primary completion
- 2019-11-30
- Enrollment
- 809
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.